Listed

Opus Genetics, Inc.

IRDNasdaqCIK 1228627HealthcareFiscal year ends Dec 31

Reports and events: 309 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Opus Genetics, Inc., Reports and events
FiledFormWhat it isAccession number
2025-01-2416:34 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001140361-25-001899
2025-01-2317:20 ET8-K8.01 Other events0001140361-25-001819
2025-01-1409:10 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-25-001013
2025-01-0717:10 ET8-K/A9.01 Financial statements and exhibits0001140361-25-000467
2024-11-1209:29 ET10-QQuarterly reportPeriod 2024-09-300001140361-24-046045
2024-11-1208:23 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-24-046028
2024-10-2917:26 ETSC 13DOwnership report, active investor0001193125-24-246646
2024-10-2217:09 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-24-043915
2024-08-1316:06 ET10-QQuarterly reportPeriod 2024-06-300001140361-24-037068
2024-08-1308:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-24-036944
2024-06-1316:06 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001140361-24-030012
2024-05-1016:35 ET10-QQuarterly reportPeriod 2024-03-310001140361-24-025481
2024-05-1016:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-24-025476
2024-05-1008:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-24-025329
2024-04-2916:28 ETDEF 14AProxy statementPeriod 2024-06-110001140361-24-023004
2024-04-1716:23 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001140361-24-020320
2024-03-2716:26 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-24-015624
2024-03-0817:20 ET10-KAnnual reportPeriod 2023-12-310001140361-24-012399
2024-03-0808:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-24-012128
2024-02-1616:03 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001140361-24-008352
2023-12-0619:15 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001140361-23-056425
2023-11-2708:45 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-23-054632
2023-11-1308:48 ET10-QQuarterly reportPeriod 2023-09-300001140361-23-052749
2023-11-1308:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-23-052736
2023-11-0208:44 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-23-051009
2023-11-0116:21 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-23-050844
2023-09-2708:45 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-23-045418
2023-08-1109:27 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-23-039201
2023-08-1108:51 ET10-QQuarterly reportPeriod 2023-06-300001140361-23-039196
2023-08-0111:21 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-23-037246
2023-06-1416:31 ET8-K5.02 Departure or appointment of officers or directors0001140361-23-029848
2023-06-0917:58 ET8-K5.07 Shareholder vote results0001140361-23-029009
2023-06-0216:30 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001140361-23-028066
2023-05-1508:20 ET10-QQuarterly reportPeriod 2023-03-310001140361-23-024504
2023-05-1508:07 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-23-024502
2023-05-0116:12 ETDEF 14AProxy statementPeriod 2023-06-060001140361-23-022044
2023-04-2108:10 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-23-019505
2023-03-3017:07 ET10-KAnnual reportPeriod 2022-12-310001140361-23-014868
2023-03-3009:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-23-014674
2023-01-2516:15 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-23-002726
2022-12-0606:37 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-22-044521
2022-11-0716:16 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001140361-22-040303
2022-11-0417:01 ET10-QQuarterly reportPeriod 2022-09-300001140361-22-040029
2022-11-0416:39 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001140361-22-040018
2022-10-1411:32 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-22-037191
2022-08-1216:59 ET10-QQuarterly reportPeriod 2022-06-300001140361-22-029461
2022-08-1207:51 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-22-029352
2022-06-1716:05 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001140361-22-023457
2022-06-1016:15 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001140361-22-022593
2022-05-1907:43 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001140361-22-019865

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 19:22 ET. Listed shows no prices and gives no investment advice.